Cd-ISTAb

N/A

Report date: 2025/03/18 18:11:40

Base Information

Drug NameCd-ISTAb

Drug Alias NameBacillus anthracis toxin neutralizing mAb (Integrated Biotherapeutics)Clostridium difficile toxin A/B inhibiting mAb (Integrated Biotherapeutics)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionToxin B inhibitorsToxin A inhibitors

TargetsToxin BToxin A

Therapy Area/IndicationsClostridium Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAbVacc Inc

China Registration ClassN/A

Develop Information

Active CompaniesAbVacc Inc

Inactive CompaniesN/A

Active IndicationsClostridium Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A